Series D startup

Who invested in CORXEL Pharmaceuticals

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$287Mraised across 1 round since 2026, from 1 source

Latest round
Series D, $287MJan 2026
Investors
6
See who backed them

The rounds

  1. Jan 2026

Everyone who backed them

RA Capital ManagementPrivate equity1round
SR OneCorporate VC1round
TCGPrivate equity1round
RTW Investments LLCGrowth equity1round
Adage Capital ManagementAsset manager1round
TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CORXEL Pharmaceuticals

Who invested in CORXEL Pharmaceuticals?

CORXEL Pharmaceuticals's investors include RA Capital Management, SR One, TCG, RTW Investments LLC and Adage Capital Management, and 1 more on record.

How much has CORXEL Pharmaceuticals raised?

CORXEL Pharmaceuticals has raised $287M across 1 round since 2026.

When did CORXEL Pharmaceuticals last raise?

CORXEL Pharmaceuticals's most recent round was a Series D of $287M in Jan 2026.

What was CORXEL Pharmaceuticals's biggest round?

Its most recent round, $287M in Jan 2026, is also its largest on record.

Who backed CORXEL Pharmaceuticals first?

CORXEL Pharmaceuticals's first round on record, in Jan 2026, was backed by RA Capital Management, SR One and TCG and 3 others.

What stage is CORXEL Pharmaceuticals at?

CORXEL Pharmaceuticals's latest named round is a Series D, in Jan 2026.

Companies like CORXEL Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.